PPG Board of Directors recognized as ‘Public Company Board of the Year’
PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE PPG) today announced its Board of Directors was recognized by the National…
Year: 2023
Atomic Revolutionizes Payroll System Integrations with SmartAuth, its Groundbreaking AI-Powered Authentication Engine
SALT LAKE CITY–(BUSINESS WIRE)–Atomic, a leading provider of payroll system integrations, has unveiled SmartAuth, a…
Wolters Kluwer Experts to Share Insights at 2023 Risk Americas Conference
Wolters Kluwer Finance, Risk & Regulatory Reporting executives will offer banks perspective on achieving a…
Soluna Obtains 14 Month Extension on Convertible Notes
Agreement Shows Confidence in Business Plan ALBANY, N.Y.–(BUSINESS WIRE)–Soluna Holdings, Inc. (“SHI” or the “Company”),…
Coloured Ties Provides Lithium Portfolio Update and Quebec Pegmatite Go Public Announcement
Vancouver, British Columbia–(Newsfile Corp. – May 12, 2023) – Coloured Ties Capital Inc. (TSXV: TIE)…
VinFast To Publicly List Through Business Combination With Black Spade Acquisition Co
HONG KONG, May 12, 2023 – (ACN Newswire) – VinFast Auto Pte. Ltd. (“VinFast” or…
Buxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Continued Evidentially False Statements of Financials
NEW YORK–(BUSINESS WIRE)–The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or…
IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
– Randomized clinical trial of IGM-8444 plus FOLFIRI and bevacizumab in second line metastatic colorectal…
Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder
IMCA medical center’s ethics committee approves clinical trial using proprietary CMND-100 treatment in Israel Tel…
UPDATE — Landos Biopharma Provides Business Update and Reports First Quarter 2023 Results
NEXUS Phase 2 Clinical Trial of NX-13 for Ulcerative Colitis Initiated NEXUS Top-line Results Planned…
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
Table 1 FDA Required Primary Efficacy Endpoint Figure 2 Study BDX-22-006 Primary Endpoint Figure 3…
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
MIAMI, May 12, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the…
Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
Palisade Bio Reports First Quarter 2023 Financial Results
Company has sufficient cash expected to fund operations through 2024 Carlsbad, CA, May 12, 2023 (GLOBE…
Freeline Completes ADS Ratio Change
LONDON, May 12, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced…
Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments
OXFORD, United Kingdom, May 12, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) (the Company,…
MediWound to Report First Quarter 2023 Financial Results
Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time YAVNE,…
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022…
BiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directors
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 12, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
Salarius Pharmaceuticals Announces $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
HOUSTON, May 12, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…